Research

Clinical Oncology

Onco-hematological Diseases
Oncologia Clínica

Our research group conducts clinical trials to assess new therapeutic strategies, the effectiveness of target treatments, and the detection of residual disease, and research studies to evaluate prognostic and predictive molecular biomarkers, the molecular mechanisms of action and resistance to drugs, and pharmacogenetics of cancer. We have expanded our research group to include trials based in radiopharmacs and theratognosis, making nuclear medicine a key strategic collaborator in our trials. We aim to identify minimal residual disease, improve individualization of therapy, work in translational research, and collaborate to expand the armamentarium against cancer.

Main lines of research

  • Breast cancer. (Tibau Martorell, Ariadna; Arqueros Nuñez, Cristina; Andres Granyo, Marta; Escuin Borras, Daniel; Rivera, Pablo).
  • Lung cancer and melanoma. (Majem Tarruella, Margarita; Barba Joaquin, Andres, Martínez Recio Sergio).
  • Neuroendocrine tumors. (Paez Lopez-Bravo, David).
  • Head and neck and Central neural tumors. (Gallego Rubio, Oscar Salvador, Aguado Sorolla, Nuria).
  • Hereditary cancer and genetic counseling. (Ramírez de Olano Galdona, Amaya; Lopez Sanmartin, Consuelo).
  • Digestive tumors. (Paez Lopez-Bravo, David; Virgili Manrique, Anna Cristina; Cerda Serda, Paula, Nieva Muñoz, Maria).
  • Urological tumors. (Maroto Rey, Jose Pablo; Anguera Palacios, Georgia, Portu Grive Mikel).
  • Sarcoma unit. (Sebio Garcia, Ana; Teres Lleida, Raul; Sebio Garcia, Ana, Aguado Sorolla María).
  • Laboratory of translational research. (Escuin Borras, Daniel; Salazar Blanco, Juliana).

Scientific Challenges

  • To increase our budget dedicated to translational research, increasing the number of projects.
  • To increase our cooperation with other research groups in the IR and with the university.
  • To increase our participation in stable cooperative research groups in cancer (CIBER, RETICS, etc).
  • To improve our success rate in national and international competitive grant calls and postdoctoral and clinical research fellowships.
  • To promote translational research in cancer in cooperation with other internal and external research groups.
  • To develop new drugs in phase 0/1 studies.

Contact

José Pablo Maroto
jmaroto@santpau.cat

Other research groups